Tempus AI (NASDAQ:TEM) Trading Up 2.6% – Time to Buy?

Tempus AI, Inc. (NASDAQ:TEM)’s stock price was up 2.6% on Wednesday . The stock traded as high as $52.00 and last traded at $48.88. Approximately 13,657,104 shares were traded during trading, an increase of 97% from the average daily volume of 6,929,281 shares. The stock had previously closed at $47.64.

Analyst Upgrades and Downgrades

Several brokerages recently commented on TEM. Needham & Company LLC reaffirmed a “buy” rating and issued a $56.00 target price on shares of Tempus AI in a research report on Tuesday, January 14th. Piper Sandler reaffirmed a “neutral” rating and set a $70.00 price objective (up from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Stifel Nicolaus lowered shares of Tempus AI from a “buy” rating to a “hold” rating and lifted their target price for the company from $45.00 to $65.00 in a research report on Monday, November 11th. Guggenheim began coverage on shares of Tempus AI in a research report on Monday, December 9th. They issued a “buy” rating and a $74.00 price target for the company. Finally, Wolfe Research assumed coverage on shares of Tempus AI in a research note on Friday, December 13th. They set an “outperform” rating and a $60.00 price target for the company. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $56.36.

Tempus AI Price Performance

The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The business’s 50 day moving average price is $44.38 and its 200-day moving average price is $47.46.

Insider Buying and Selling at Tempus AI

In other news, CEO Eric P. Lefkofsky sold 187,655 shares of the company’s stock in a transaction that occurred on Wednesday, December 18th. The shares were sold at an average price of $37.54, for a total transaction of $7,044,568.70. Following the transaction, the chief executive officer now directly owns 9,557,283 shares in the company, valued at approximately $358,780,403.82. This represents a 1.93 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Andrew Polovin sold 51,504 shares of the firm’s stock in a transaction that occurred on Wednesday, December 11th. The shares were sold at an average price of $42.39, for a total transaction of $2,183,254.56. Following the completion of the sale, the executive vice president now directly owns 246,085 shares of the company’s stock, valued at approximately $10,431,543.15. This represents a 17.31 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,862,758 shares of company stock worth $79,585,675.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of TEM. First Horizon Advisors Inc. acquired a new stake in shares of Tempus AI during the third quarter worth $30,000. FNY Investment Advisers LLC acquired a new position in shares of Tempus AI during the 4th quarter worth about $67,000. Vestor Capital LLC bought a new stake in shares of Tempus AI in the 3rd quarter valued at about $153,000. Stifel Financial Corp acquired a new stake in Tempus AI in the third quarter worth $218,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd acquired a new stake in Tempus AI during the 3rd quarter worth $258,000. Institutional investors own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.